An Anesthetic Management of Takayasu Arteritis with Aortic Regurgitation in a Parturient Posted for Cesarean Section
Annals of African Medicine · 2025
DOI: 10.4103/aam.aam_243_24 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of African Medicine, 2025. Verfasst von Ashna Shetty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Karnataka, Manipal, India. Hauptthemen laut MEDLINE: Takayasu Arteritis, Cesarean Section, Aortic Valve Insufficiency, Anesthesia, Obstetrical. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Takayasu arteritis is an idiopathic, chronic, and inflammatory condition that mostly affects the aorta and its branches. Nearly 80% of occurrences involve females who are in their reproductive years. Although there is no effect on the disease’s progression during pregnancy, these patients should be monitored for blood pressure (BP) changes and restricted intrauterine growth because they can develop complications such as hypertension, multiple organ dysfunction, and stenosis that reduces regional blood flow. Anesthetic implications of Takayasu arteritis include uncontrolled hypertension, maintenance of mean arterial pressure which is adequate to maintain end organ function, difficulty in monitoring of arterial pressure and tight maintenance of fluid regime. Case Presentation: A 31-year-old parturient, Gravida 3 Para 2 Living 0, hailing from north part of Karnataka, known hypertensive with previous lower segment cesarean section (LSCS) was a diagnosed case with Takayasu arteritis presented to us for elective LSCS. She had ahistory of two previous deaths of her neonate immediately following delivery. Moreover, on further evaluation was diagnosed with the above condition. Although a diagnosed case, she was never put on any treatment for the same. She was otherwise healthy carrying out her routine work without any discomfort. Her two-dimensional echo revealed severe aortic regurgitation. Rheumatology and CTVS opinion were taken. Cesarean section was planned under combined spinal epidural taking into account her clinical state and hemodynamics.
Conclusion
Pregnant women with Takayasu arteritis may experience an array of complications. Careful patient evaluation, treatment of TA and its complications, formulating anesthetic plan are fundamental. The key issue for these individuals is maintaining perfusion. Regional anesthesia is a safe anesthetic treatment that offers thorough preanesthetic examination and close monitoring of neurological status and BP for cesarean sections in pregnant women with Takayasu arteritis. Avoiding hemodynamic alterations and maintaining organ perfusion during the perioperative period are the most crucial objectives. To avoid postoperative complications, the patient should be monitored in an intensive care unit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Karnataka, Manipal, India.
Zitieren
APA
Shetty, A., Akshatha, D., Naik, S. A., Ranjan, R. K., Cutinha, F. P., & Siddappa, P. (2025). An Anesthetic Management of Takayasu Arteritis with Aortic Regurgitation in a Parturient Posted for Cesarean Section. Annals of African Medicine. https://doi.org/10.4103/aam.aam_243_24
Vancouver
Shetty A, Akshatha D, Naik SA, Ranjan RK, Cutinha FP, Siddappa P. An Anesthetic Management of Takayasu Arteritis with Aortic Regurgitation in a Parturient Posted for Cesarean Section. Annals of African Medicine. 2025. doi:10.4103/aam.aam_243_24
BibTeX
@article{Shetty2025,
author = {Shetty, Ashna and Akshatha, D and Naik, Shilpa A and Ranjan, R K and Cutinha, Freeda Praveena and Siddappa, Prajwal},
title = {An Anesthetic Management of Takayasu Arteritis with Aortic Regurgitation in a Parturient Posted for Cesarean Section},
journal = {Annals of African Medicine},
year = {2025},
doi = {10.4103/aam.aam_243_24}
}
EUVIMED